| P50 | author | Chun-Ta Liao | Q113027396 |
| P2093 | author name string | Joseph Tung-Chieh Chang | |
| | Tzu-Chen Yen | |
| | Cheng-Lung Hsu | |
| | Chien-Yu Lin | |
| | Hung-Ming Wang | |
| | Shiang-Fu Huang | |
| | Chia-Hsun Hsieh | |
| | Kang-Hsing Fan | |
| | Pei-Wei Huang | |
| | Shu-Kung Ng | |
| P2860 | cites work | Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity | Q27313572 |
| | Global burden of cancers attributable to infections in 2008: a review and synthetic analysis | Q29620303 |
| | Cisplatin, tegafur, and leucovorin: a moderately effective and minimally toxic outpatient neoadjuvant chemotherapy for locally advanced squamous cell carcinoma of the head and neck | Q33343214 |
| | Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer | Q33377142 |
| | Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation | Q33383864 |
| | A phase II study of combined oral uracil and ftorafur with leucovorin for patients with squamous cell carcinoma of the head and neck | Q34315576 |
| | Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial | Q34328071 |
| | Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial | Q35169306 |
| | Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer | Q36625201 |
| | Pharmacoethnicity of docetaxel-induced severe neutropenia: integrated analysis of published phase II and III trials. | Q37957744 |
| | Incidence trends of human papillomavirus-related head and neck cancer in Taiwan, 1995-2009. | Q41662661 |
| | Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients | Q43681440 |
| | Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study | Q43772035 |
| | A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer | Q43821393 |
| | Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer: 10-year follow-up. | Q45152760 |
| | Phase II trial of cisplatin, tegafur plus uracil and leucovorin as neoadjuvant chemotherapy in patients with squamous cell carcinoma of the oropharynx and hypopharynx | Q45300007 |
| | Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer | Q46932585 |
| | Concurrent chemoradiotherapy using cisplatin, tegafur, and leucovorin for advanced squamous cell carcinoma of the hypopharynx and oropharynx | Q50354993 |
| | Prognostic impact of p16, p53, epidermal growth factor receptor, and human papillomavirus in oropharyngeal cancer in a betel nut-chewing area. | Q51770826 |
| | Cisplatin and 5-fluorouracil as neoadjuvant chemotherapy: predicting response in head and neck squamous cell cancer | Q71883302 |
| | Clinical experience with tegafur and low dose oral leucovorin: a dose-finding study | Q72542442 |
| | Impact of oral submucous fibrosis on chemotherapy-induced mucositis for head and neck cancer in a geographic area in which betel quid chewing is prevalent | Q73082463 |
| P433 | issue | 2 | |
| P921 | main subject | phase II clinical trial | Q42824440 |
| P304 | page(s) | 129-136 | |
| P577 | publication date | 2018-04-01 | |
| P1433 | published in | Biomedical journal | Q26853827 |
| P1476 | title | A phase II randomized trial comparing neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in advanced squamous cell carcinoma of the pharynx or larynx | |
| P478 | volume | 41 | |